Cochrane Evidence Synthesis and Methods ►

Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

We will perform a network meta-analysis to assess the relative effectiveness and safety of immunomodulatory and immunosuppressive treatments for people with multiple sclerosis in progressive forms of the condition.

This is a protocol.

Published:

3 November 2022

Authors:

Ridley B, Minozzi S, Gonzalez-Lorenzo M, Del Giovane C, Filippini G, Peryer G, Foschi M, Tramacere I, Baldin E, Nonino F

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Ridley B, Minozzi S, Gonzalez-Lorenzo M, Del Giovane C, Filippini G, Peryer G, Foschi M, Tramacere I, Baldin E, Nonino F. Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 11. Art. No.: CD015443. DOI: 10.1002/14651858.CD015443.